Press Releases

BrioHealth Solutions, Inc., a medical technology company focused on developing innovative advanced heart failure solutions, today announced it has received FDA Investigational Device Exemption (IDE) approval with conditions to commence enrollment in its landmark INNOVATE trial. The study will assess the effectiveness and safety of its novel BrioVAD™ System, a magnetically levitated ventricular assist device, in treating refractory left ventricular heart failure. With the notice, BrioHea

The American Association of Kidney Patients (AAKP), the oldest and largest independent kidney patient consumer organization in the U.S., is raising public awareness on May 1, National High Potassium Awareness Day, about the devastating impacts of unmanaged potassium levels in individuals with chronic kidney disease (CKD). Nearly three million Americans with CKD and/or heart failure live with high potassium levels. Many people with CKD, including those with kidney failure, cannot pro

InterSystems, a creative data technology provider dedicated to helping customers solve the most critical scalability, interoperability and speed problems, today announced a collaboration with Consultmed, an Australian provider of a referral management and automated workflow platform connecting primary care providers, medical specialists and hospitals. As part of the collaboration, Consultmed will replatform its software on InterSystems IRIS for Health™, accelerating and reducing costs o

Caristo Diagnostics, a leading cardiac disease diagnostics company, has been named by Newsweek as one of World's Best Digital Health Companies in diagnostics. Newsweek's inaugural ranking of the World's Best Digital Health Companies includes 400 companies in seven segments including diagnostics, health records, medical management and telehealth. The ranking is based on in-depth analysis of thousands of companies' financial performance and traffic data for websites an

AriBio announced authorisation from the European Medicines Agency (EMA) for POLARIS-AD (AR1001-ADP3-US01), a global, phase 3, early Alzheimer’s disease clinical trial. EMA now aligns with the U.S. Food and Drug Administration (FDA) and UK Medicines and Healthcare Products Regulatory Agency (MHRA) on the Clinical Trial Authorisation of POLARIS-AD. The final decision from EMA was completed on April 24th with clinical trial approvals in the following member states: Czech Rep

Mangoceuticals, a company focused on developing, marketing, and selling a variety of men’s health and wellness products in the area of erectile dysfunction (ED), hair growth and hormone replacement therapies is excited to announce that it has acquired a global patent portfolio for a pioneering oral solution and application aimed to combat and prevent a spectrum of infections, including the common cold, respiratory diseases, and orally transmitted diseases such as human papillomavirus (H

BioIntelliSense, a continuous health monitoring and clinical intelligence company, announces completion of Houston Methodist’s inpatient expansion of the BioButton® continuous patient monitoring solution across all 2,653 non-ICU beds at the system’s eight hospitals. The FDA-cleared BioIntelliSense BioButton multiparameter wearable is applied to patients at the time of admission with centralized command center monitoring by Houston Methodist’s mu

Concert Health, the leading Collaborative Care platform, and the Advancing Integrated Mental Health Solutions (AIMS) Center in the University of Washington Department of Psychiatry and Behavioral Sciences, today announced a three year, multi-state project to facilitate mental health care for 2,700 patients with complex psychiatric disorders in primary care settings. Specifically, the project will leverage and scale a Telepsychiatry Collaborative Care Model (CoCM) to help identify and treat pa

Revna Biosciences has carved a niche for itself in Ghana and West Africa by being the first facility in the region to secure dual ISO accreditations: ISO 15189:2022 for clinical diagnostics and ISO 20387:2018 for biobanking. This milestone is a testament to RevnaBio’s unwavering commitment to championing precision medicine by propelling molecular diagnostics and therapeutic discovery in the region. A Pledge to Quality and Patient Care The Americ

A groundbreaking agreement between MSC Group, MSC Foundation and the charity Mercy Ships International prepares for the construction of a brand-new hospital ship that will deliver free surgery and training annually to thousands of people in Africa. On 8 April, the chairman of MSC Group and MSC Foundation, Capt. Gianluigi Aponte, Diego Aponte, MSC Group President and Member of the MSC Foundation Board, and Mercy Ships Founder Don Stephens finalised an agreement to kickstart this new